Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
One of the largest IT companies, T1, has gained control over the developer of solutions based on distributed registry technologies, Distributed Registry Systems. T1 IT Holding acquired 33.3% in ...
WebMD LLC ("WebMD") may revise and update these Terms and Conditions at any time. Your continued usage of the WebMD website ("WebMD Site," or the "Site,") will mean you accept those changes. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback